539 results on '"Spagnoli, Giulio C"'
Search Results
2. Immune response profiles induced by silk-based biomaterials: a journey from 'immunogenicity' towards 'immuno-compatibility.
3. Prognostic significance of CD8+ T-cells density in stage III colorectal cancer depends on SDF-1 expression
4. Assessing Autophagy During Retinoid Treatment of Breast Cancer Cells
5. Supplementary Materials and Methods from Characterization and Clinical Relevance of ALDHbright Populations in Prostate Cancer
6. Supplementary Table 2 from The Interplay Between Neutrophils and CD8+ T Cells Improves Survival in Human Colorectal Cancer
7. Supplementary Figure 2 from Characterization and Clinical Relevance of ALDHbright Populations in Prostate Cancer
8. Supplementary Figure 3 from The Interplay Between Neutrophils and CD8+ T Cells Improves Survival in Human Colorectal Cancer
9. Supplementary Figure 2 from GM-CSF Production by Tumor Cells Is Associated with Improved Survival in Colorectal Cancer
10. Supplementary Figure 2 from The Interplay Between Neutrophils and CD8+ T Cells Improves Survival in Human Colorectal Cancer
11. Supplementary Table 1 from Characterization and Clinical Relevance of ALDHbright Populations in Prostate Cancer
12. Supplementary Figure 1 from The Interplay Between Neutrophils and CD8+ T Cells Improves Survival in Human Colorectal Cancer
13. Supplementary Table 2 from Characterization and Clinical Relevance of ALDHbright Populations in Prostate Cancer
14. Legend from The Interplay Between Neutrophils and CD8+ T Cells Improves Survival in Human Colorectal Cancer
15. Supplementary Table 1 from The Interplay Between Neutrophils and CD8+ T Cells Improves Survival in Human Colorectal Cancer
16. Supplementary Figure 1 from Characterization and Clinical Relevance of ALDHbright Populations in Prostate Cancer
17. Supplementary Figure 1 from GM-CSF Production by Tumor Cells Is Associated with Improved Survival in Colorectal Cancer
18. Supplementary Table 3 from Modulation of T-Cell Activation by Malignant Melanoma Initiating Cells
19. Data from Modulation of T-Cell Activation by Malignant Melanoma Initiating Cells
20. Supplementary Table 1 from Modulation of T-Cell Activation by Malignant Melanoma Initiating Cells
21. Supplementary Table 2 from Modulation of T-Cell Activation by Malignant Melanoma Initiating Cells
22. Supplementary Methods and Materials from Modulation of T-Cell Activation by Malignant Melanoma Initiating Cells
23. MAGE-A4 and MAGE-A1 Immunohistochemical Expression in High-grade Endometrial Cancer
24. “In vitro” 3D models of tumor-immune system interaction
25. Direct CD32 T-cell cytotoxicity: implications for breast cancer prognosis and treatment
26. The role of 3D structure and protein conformation on the innate and adaptive immune responses to silk-based biomaterials
27. Cytotoxic T-cell Induction in Metastatic Melanoma Patients Undergoing Recombinant Vaccinia Virus-based Immuno-gene Therapy
28. Interferon-α Sensitivity in Melanoma Cells: Detection of Potential Response Marker Genes
29. Identification of TPM2 and CNN1 as Novel Prognostic Markers in Functionally Characterized Human Colon Cancer-Associated Stromal Cells
30. Identification of TPM2 and CNN1 as Novel Prognostic Markers in Functionally Characterized Human Colon Cancer-Associated Stromal Cells
31. High Density of CD16+ Tumor-Infiltrating Immune Cells in Recurrent Ovarian Cancer Is Associated with Enhanced Responsiveness to Chemotherapy and Prolonged Overall Survival
32. FGF2 induces RANKL gene expression as well as IL1β regulated MHC class II in human bone marrow-derived mesenchymal progenitor stromal cells
33. Nestin and CD34 expression in colorectal cancer predicts improved overall survival
34. Uptake routes of tumor-antigen MAGE-A3 by dendritic cells determine priming of naïve T-cell subtypes
35. Expression of cancer testis antigens in human BRCA-associated breast cancers: potential targets for immunoprevention?
36. Active Specific Immunotherapy Phase III Trials for Malignant Melanoma: Systematic Analysis and Critical Appraisal
37. Heterologous prime-boost immunotherapy of melanoma patients with Influenza virosomes, and recombinant Vaccinia virus encoding 5 melanoma epitopes and 3 co-stimulatory molecules. A multi-centre phase I/II open labeled clinical trial
38. New dimensions in tumor immunology: what does 3D culture reveal?
39. Mesenchymal stromal cells induce epithelial-to-mesenchymal transition in human colorectal cancer cells through the expression of surface-bound TGF-β
40. Fibrosis and cancer: shared features and mechanisms suggest common targeted therapeutic approaches.
41. Nestin and CD34 expression in colorectal cancer predicts improved overall survival
42. Supplemental Material, Supplemental_tables - Tumor Infiltration by OX40+ Cells Enhances the Prognostic Significance of CD16+ Cell Infiltration in Colorectal Cancer
43. Active Antigen-specific Immunotherapy of Melanoma: from Basic Science to Clinical Investigation
44. Fibrosis and cancer: shared features and mechanisms suggest common targeted therapeutic approaches
45. MAGE-A10 cancer/testis antigen is highly expressed in high-grade non-muscle-invasive bladder carcinomas
46. Immunogenicity of nonreplicating recombinant vaccinia expressing HLA-A201 targeted or complete MART-1/Melan-A antigen
47. Effect of IL-1 on the hydrolysis of the tumor antigen epitope gp100 280–288 by fibroblast-expressed enzymes
48. MHC–peptide specificity and T-cell epitope mapping: where immunotherapy starts
49. Expression of MAGE antigens and analysis of the inflammatory T-cell infiltrate in human seminoma
50. T Cell Epitope-Mapping by Cytokine Gene Expression Assay
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.